Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population

Figure 1 Single nucleotide polymorphisms in patients with or without metabolic dysfunction-associated fatty liver disease. The bar charts represent the percent of each allele comparing metabolic dysfunction-associated fatty liver disease (MAFLD) patients (blue) and controls (green). ¹Chi-squared test; ²Fisher’s exact test.